eXp World (EXPI) Q2 Profit Falls 113%

eXp World (NASDAQ:EXPI) reported a challenging Q2 2025, with GAAP EPS of $(0.01) significantly missing analyst expectations and marking a reversal from prior year's profit, despite revenue rising 1% to $1.31 billion, slightly above forecasts. Profitability was severely impacted, with adjusted EBITDA plummeting 65.9% to $11.2 million, driven by a 20% surge in adjusted operating costs and a $17.0 million antitrust settlement. The company noted a decline in agent and transaction counts, offset by higher sales volume per agent, as it continues to invest in technology and international expansion without providing explicit forward guidance.

Analysis

eXp World (EXPI) reported a challenging second quarter for fiscal 2025, characterized by a significant deterioration in profitability despite marginal revenue growth. While revenue increased 1% year-over-year to $1.31 billion, narrowly beating estimates, the company posted a GAAP EPS of $(0.01), a stark miss against the projected $0.10 and a reversal from a $0.08 profit in the prior year. The primary driver of this underperformance was a 20% surge in adjusted operating costs, which crushed margins and caused adjusted EBITDA to plummet 65.9% to $11.2 million. This cost increase was attributed to investments in technology, operational streamlining, and severance. Operationally, the narrative is mixed; total agent and transaction counts declined by 5% and 2% respectively, but real estate sales volume grew 1% to $52.5 billion, suggesting a potential consolidation around higher-producing agents. However, the company's financial health showed signs of strain, with adjusted operating cash flow falling 77.8% and the cash balance reduced by a $17.0 million antitrust settlement payment. Despite these pressures, eXp World distributed $32.6 million to shareholders via dividends and buybacks. The lack of explicit forward guidance from management introduces significant uncertainty regarding the trajectory of cost control and the financial payoff from its ongoing international and technological investments.

Key Decisions for Investors

• Investors should exercise caution due to the severe margin compression and the 65.9% decline in adjusted EBITDA, which signals fundamental weakness in core profitability despite slight revenue growth.
• Monitor whether the modest 1% increase in sales volume can sustainably offset the 5% decline in agent count, as this is a critical test of the company's agent-centric model and value proposition.
• The 77.8% drop in adjusted operating cash flow, coupled with continued capital returns, raises questions about the sustainability of the dividend and buyback programs; scrutinize the balance sheet and cash generation in subsequent quarters.
• The absence of forward guidance creates significant uncertainty, making it prudent to wait for concrete evidence of successful cost management and a stabilization in profitability before increasing exposure.